期刊文献+

丹栀逍遥汤联合丁螺环酮治疗抑郁症的临床效果 被引量:3

下载PDF
导出
摘要 目的:探讨丹栀逍遥汤联合丁螺环酮治疗抑郁症的临床效果研究。方法:选择2017年5月至2019年1月治疗的抑郁症患者62例作为对象,随机数字表分为对照组(n=31)和观察组(n=31)。对照组给予丁螺环酮治疗,观察组在对照组基础上联合丹栀逍遥汤治疗,2个疗程治疗后对患者效果进行评估,根据汉密尔顿抑郁量表(HAMD),观察两组患者治疗前后HAMD评分及治疗后的不良反应发生率。结果:治疗前,两组患者HAMD评分比较,差异无统计学意义(P> 0.05);观察组治疗后1个疗程、2个疗程的HAMD评分均低于对照组,差异具有统计学意义(P <0.05);对照组患者治疗后不良反应率为19.35%,观察组患者治疗后不良反应率为12.90%,观察组患者治疗后的不良反应发生率低于对照组,差异具有统计学意义(P <0.05)。结论:丹栀逍遥汤联合丁螺环酮治疗抑郁症的临床效果显著,可以有效降低患者的抑郁情绪,改善患者抑郁症状,减少不良反应。
作者 高超
出处 《深圳中西医结合杂志》 2019年第7期27-28,共2页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献6

二级参考文献51

  • 1Devanand DP.Comorbid psychiatric disorders in late depression[J].Biol Psychiatry,2002,52(3):236.
  • 2Lenze EJ,Mulsant BH,Shear MK,et al.Comorbid anxiety disorders in depressed elderly patients[J].Am J Psychiatry,2000,157(5):722.
  • 3Jacoby R.Psychiatry in the elderly[M].2nd.New York:Oxford University Press,1997:536-573.
  • 4Thase ME,Shelton RC,Khan A.Treatment with venlafaxine extended release after SSRI nonresponse orintolerance:a randomized comparison of standard 2 and higher 2dosing strategies[J].J Clin Psychopharmacol,2006,26(3):250.
  • 5Moroz G.High potency benzodiazepines:recent clinical results[J].Clin J Psychiatry,2004,65(5):13.
  • 6Gobert A,Rivet JM,Cistarelli L,et al.Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine,noradrenaline and serotonin in the frontal cortex of freely moving rats:activation of serotonin1A receptors and blockade ofα2-adrenergic receptors underlie its actions[J].Neuroscience,1999,93(4):1 251.
  • 7Gross C,Zhuang X,Stark K,et al.Serotoninl A receptor acts during development to establish normal anxiety-like behavior in the adult[J].Nature,2002,416(6 879):396.
  • 8Sato H,Skelin I,Diksic M.Chronic buspirone treatment decreases 5-HT1BReceptor densitises and the serotonin transporter but increases the density of 5-HT2Areceptors in the bulbectomized rat model of depression:an autoradiograpic study[J].Brain Res,2010,1 345:28.
  • 9Loane C,Politis M.Buspirone:what is it all about?[J].Brain Research,2012,1 461:111.
  • 10Fang Y,Yuan C,Xu Y,et al.A pilot study of the efficacy and safety of paroxetine augmented with risperidone,valproate,buspirone,trazodone,or thyroid hormone in adult chinese patients with treatment-resistant major depression[J].J Clin Psychopharmacol,2011,31(5):1.

共引文献85

同被引文献42

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部